PL365131A1 - Metoda skriningu - Google Patents

Metoda skriningu

Info

Publication number
PL365131A1
PL365131A1 PL01365131A PL36513101A PL365131A1 PL 365131 A1 PL365131 A1 PL 365131A1 PL 01365131 A PL01365131 A PL 01365131A PL 36513101 A PL36513101 A PL 36513101A PL 365131 A1 PL365131 A1 PL 365131A1
Authority
PL
Poland
Prior art keywords
sequences
polynucleotides
gene
proteins
peptides
Prior art date
Application number
PL01365131A
Other languages
English (en)
Inventor
Clemens Gillen
Ingrid Wetzels
Stephan Wnendt
Eberhard Weihe
Martin K.H. Schafer
Original Assignee
Grunenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grunenthal Gmbh filed Critical Grunenthal Gmbh
Publication of PL365131A1 publication Critical patent/PL365131A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2842—Pain, e.g. neuropathic pain, psychogenic pain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL01365131A 2000-08-03 2001-08-03 Metoda skriningu PL365131A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10037759A DE10037759A1 (de) 2000-08-03 2000-08-03 Screeningverfahren
PCT/EP2001/009011 WO2002012338A2 (de) 2000-08-03 2001-08-03 Screeningverfahren

Publications (1)

Publication Number Publication Date
PL365131A1 true PL365131A1 (pl) 2004-12-27

Family

ID=7651135

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365131A PL365131A1 (pl) 2000-08-03 2001-08-03 Metoda skriningu

Country Status (14)

Country Link
US (1) US20040087478A1 (pl)
EP (2) EP1469316B1 (pl)
JP (1) JP2004537962A (pl)
AT (2) ATE344458T1 (pl)
AU (1) AU2001282066A1 (pl)
CA (1) CA2417972A1 (pl)
DE (3) DE10037759A1 (pl)
DK (1) DK1305636T3 (pl)
ES (2) ES2276192T3 (pl)
HU (1) HUP0301812A2 (pl)
MX (1) MXPA03001015A (pl)
PL (1) PL365131A1 (pl)
PT (1) PT1305636E (pl)
WO (1) WO2002012338A2 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE397090T1 (de) * 2001-05-23 2008-06-15 Boehringer Ingelheim Pharma Verfahren und verbindungen zur diagnose von entzündlichen erkrankungen und identifizierung von pharmakologischen mitteln zur behandlung von entzündlichen erkrankungen
DE60237236D1 (de) * 2001-06-28 2010-09-16 Millenium Pharmaceuticals Inc Ein mitglied der menschlichen proteinkinasefamilie, und verwendungen dafür
US20050119206A1 (en) * 2002-03-14 2005-06-02 Develogen Aktiengesellschaft Fuerentwicklungsbolog Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis
DE10226702A1 (de) * 2002-06-14 2004-09-09 Grünenthal GmbH Antisense Oligonukleotide gegen PIM1
WO2004070383A2 (de) * 2003-02-05 2004-08-19 Grünenthal GmbH Identifizierung schmerzegulierter gene im drg nach cfa-arthritits
ES2307381B1 (es) 2006-04-12 2009-10-23 Bial Industrial Farmaceutica S.A. Proteinas quimericas hipoalergenicas pertenecientes a la familia de transportadoras de lipidos de parietaria judaica utiles para el tratami ento de alergias.
US8642334B2 (en) 2009-02-17 2014-02-04 Memorial Sloan Kettering Cancer Center Methods of neural conversion of human embryonic stem cells
NZ724971A (en) 2010-02-24 2019-06-28 Immunogen Inc Folate receptor 1 antibodies and immunoconjugates and uses thereof
CA2800500C (en) 2010-05-25 2019-10-15 Memorial Sloan-Kettering Cancer Center Method of nociceptor differentiation of human embryonic stem cells and uses thereof
KR20230013283A (ko) 2011-04-01 2023-01-26 이뮤노젠 아이엔씨 Folr1 암 치료의 효능을 증가시키기 위한 방법
ES2779453T3 (es) 2011-11-04 2020-08-17 Memorial Sloan Kettering Cancer Center Neuronas de dopamina (DA) del mesencéfalo para injerto
EP2809800A1 (en) 2012-01-30 2014-12-10 VIB vzw Means and method for diagnosis and treatment of alzheimer's disease
PL2890717T3 (pl) 2012-08-31 2020-08-10 Immunogen, Inc. Testy i zestawy diagnostyczne do wykrywania receptora folianu
EP2989198A4 (en) 2013-04-26 2016-10-26 Sloan Kettering Inst Cancer CORTICAL INTERNEURONES AND OTHER NEURONAL CELLS PRODUCED BY DIRECTED DIFFERENTIATION OF PLURIPOTENT AND MULTIPOTENT CELLS
AU2014312086B2 (en) 2013-08-30 2020-03-12 Immunogen, Inc. Antibodies and assays for detection of folate receptor 1
MA42844A (fr) 2015-09-17 2018-07-25 Immunogen Inc Combinaisons thérapeutiques comprenant des immunoconjugués anti-folr1
WO2019126186A1 (en) 2017-12-18 2019-06-27 Neon Therapeutics, Inc. Neoantigens and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2148898A1 (en) * 1994-05-09 1995-11-10 John M. Kyriakis P54 stress-activated protein kinases
JPH09163988A (ja) * 1995-10-09 1997-06-24 Kowa Co 新規なｌｄｌ受容体類似蛋白質及び遺伝子
EP0948604B1 (en) * 1996-12-11 2004-07-21 Sugen, Inc. Screening methods for compounds binding to the Pyk2 polypeptide
WO1998045704A2 (en) * 1997-04-07 1998-10-15 Bioimage A/S A method for extracting quantitative information relating to an influence on a cellular response
EP1011709A4 (en) * 1997-09-09 2003-06-18 Univ California APOPTOSE INHIBITION BY PROSAPOSIN RECEPTORAGONISTS
US6943000B2 (en) * 1997-10-03 2005-09-13 University Of Massachusetts JNK3 modulators and methods of use
US6162613A (en) * 1998-02-18 2000-12-19 Vertex Pharmaceuticals, Inc. Methods for designing inhibitors of serine/threonine-kinases and tyrosine kinases
WO2000043524A1 (fr) * 1999-01-20 2000-07-27 Aventis Pharma S.A. Polypeptides derives de jnk3
AU5316900A (en) * 1999-06-03 2000-12-28 Vertex Pharmaceuticals Incorporated Inhibitors of c-jun n-terminal kinases (jnk)
TW200302722A (en) * 2002-02-13 2003-08-16 Astrazeneca Ab Therapeutic agents
CN100368411C (zh) * 2002-03-28 2008-02-13 卫材R&D管理有限公司 作为c-Jun N-末端激酶抑制剂用于治疗神经变性疾病的7-氮杂吲哚类化合物

Also Published As

Publication number Publication date
WO2002012338A3 (de) 2002-12-19
HUP0301812A2 (hu) 2003-09-29
ES2276192T3 (es) 2007-06-16
DK1305636T3 (da) 2006-07-10
EP1469316B1 (de) 2006-11-02
CA2417972A1 (en) 2003-01-31
EP1305636A2 (de) 2003-05-02
ATE344458T1 (de) 2006-11-15
DE50111395D1 (de) 2006-12-14
MXPA03001015A (es) 2004-01-29
DE50109087D1 (de) 2006-04-27
PT1305636E (pt) 2006-07-31
DE10037759A1 (de) 2002-07-04
WO2002012338A2 (de) 2002-02-14
AU2001282066A1 (en) 2002-02-18
JP2004537962A (ja) 2004-12-24
EP1305636B1 (de) 2006-03-01
ATE319092T1 (de) 2006-03-15
ES2260267T3 (es) 2006-11-01
US20040087478A1 (en) 2004-05-06
EP1469316A8 (de) 2004-12-15
EP1469316A3 (de) 2005-01-05
EP1469316A1 (de) 2004-10-20

Similar Documents

Publication Publication Date Title
MXPA03001015A (es) Procedimiento de seleccion.
AU2008201280B2 (en) Genes with ES cell-specific expression
JP2018078889A (ja) 豚の肉質形質判断用遺伝子マーカー及びその利用
Latham et al. Stage-specific induction and regulation by genomic imprinting of the mouse U2afbp-rs gene during preimplantation development
JPH09502980A (ja) Ｎｆ−ａｔポリペプチド及びポリヌクレオチド
CA2679954A1 (en) Assessment of risk for colorectal cancer
Umeki et al. Two novel missense mutations in the thyroid peroxidase gene, R665W and G771R, result in a localization defect and cause congenital hypothyroidism
Mutai et al. PAL31, a novel nuclear protein, expressed in the developing brain
WO2000000607B1 (en) A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid
EA027258B1 (ru) Способ прогнозирования стиля передвижения у лошади и применение указанного способа для отбора лошади для разведения
CA2323091A1 (en) Nephrin gene and protein
JP2007508020A5 (pl)
WO2014110628A1 (en) Gene and mutations thereof associated with seizure disorders
CN110452970A (zh) 一种基因融合的微流控检测设备及其使用方法
JP2003529371A (ja) ヒトセリンラセマーゼ
EP1403281A4 (en) NEW LIGAND AND HIS DNA
WO2001081633A1 (en) Association of protein kinase c zeta polymorphisms with diabetes
EP1403368B1 (en) Testicular carnitine transporter and its gene
Chessa et al. Development of a SNP genotyping microarray platform for the identification of bovine milk protein genetic polymorphisms
US20020155473A1 (en) Methods for identifying G-protein coupled receptors associated with diseases
WO2004111272A2 (en) Polymorphism in the human nbs1 gene useful in diagnostic of inherited predisposition to cancer
WO2003102028A1 (fr) Proteine induite par le gene rb1 (rb1cc1) et gene
US7307145B2 (en) Sodium-independent transporter transporting small-sized neutral amino acid, gene thereof and method of analyzing transporter function by constructing fused proteins enabling the specification of the function
US7160697B2 (en) Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer
JP2022091235A (ja) アユ類の性識別マーカー

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)